Renaissance Technologies’s Cardiff Oncology CRDF Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$409K Buy
+129,690
New +$409K ﹤0.01% 2933
2025
Q1
Sell
-483,090
Closed -$2.1M 3520
2024
Q4
$2.1M Sell
483,090
-119,294
-20% -$518K ﹤0.01% 2020
2024
Q3
$1.61M Buy
602,384
+444,894
+282% +$1.19M ﹤0.01% 2160
2024
Q2
$350K Buy
157,490
+71,390
+83% +$158K ﹤0.01% 2853
2024
Q1
$460K Sell
86,100
-30,300
-26% -$162K ﹤0.01% 2899
2023
Q4
$172K Sell
116,400
-37,600
-24% -$55.6K ﹤0.01% 3182
2023
Q3
$214K Sell
154,000
-157,290
-51% -$219K ﹤0.01% 3068
2023
Q2
$458K Sell
311,290
-20,018
-6% -$29.5K ﹤0.01% 2917
2023
Q1
$547K Sell
331,308
-159,682
-33% -$264K ﹤0.01% 2834
2022
Q4
$687K Buy
490,990
+69,002
+16% +$96.5K ﹤0.01% 2751
2022
Q3
$650K Sell
421,988
-305,628
-42% -$471K ﹤0.01% 2756
2022
Q2
$1.6M Buy
727,616
+236,158
+48% +$520K ﹤0.01% 2359
2022
Q1
$1.22M Buy
+491,458
New +$1.22M ﹤0.01% 2596
2020
Q3
Sell
-268,800
Closed -$1.35M 3415
2020
Q2
$1.35M Buy
268,800
+129,091
+92% +$647K ﹤0.01% 2402
2020
Q1
$141K Sell
139,709
-177,594
-56% -$179K ﹤0.01% 3168
2019
Q4
$393K Buy
317,303
+7,700
+2% +$9.54K ﹤0.01% 2980
2019
Q3
$468K Buy
309,603
+60,482
+24% +$91.4K ﹤0.01% 2891
2019
Q2
$623K Buy
249,121
+88,900
+55% +$222K ﹤0.01% 2908
2019
Q1
$601K Buy
160,221
+45,755
+40% +$172K ﹤0.01% 2867
2018
Q4
$361K Buy
114,466
+15,032
+15% +$47.4K ﹤0.01% 2975
2018
Q3
$486K Buy
99,434
+65,467
+193% +$320K ﹤0.01% 2855
2018
Q2
$157K Buy
33,967
+32,180
+1,801% +$149K ﹤0.01% 3103
2018
Q1
$45K Buy
+1,787
New +$45K ﹤0.01% 3306
2017
Q2
Sell
-405
Closed -$33K 3207
2017
Q1
$33K Buy
+405
New +$33K ﹤0.01% 3163
2015
Q3
Sell
-1,835
Closed -$1.34M 3187
2015
Q2
$1.34M Buy
+1,835
New +$1.34M ﹤0.01% 2297